The endoplasmic reticulum stress and the unfolded protein response in kidney disease: Implications for vascular

Carlo Alberto Ricciardi1, Luigi Gnudi1

  • 1King's College of London, Faculty of Life Sciences & Medicine, School of Cardiovascular Medicine & Sciences, Section Vascular Biology and Inflammation, British Heart Foundation Centre for Research Excellence, London, UK.

Insights

Endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are key in kidney disease. Understanding these pathways may reveal new therapeutic targets for acute kidney injury (AKI) and chronic kidney disease (CKD).

Area of Science:

  • Nephrology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Acute kidney injury (AKI) and chronic kidney disease (CKD) pose significant healthcare challenges.
  • Effective therapies for kidney diseases are limited, necessitating novel biomarkers and pharmacological targets.
  • Endoplasmic reticulum (ER) stress is increasingly recognized for its role in kidney disease pathophysiology.

Purpose of the Study:

  • To review the cellular response to ER stress, including the unfolded protein response (UPR) pathways (PERK, IRE1α, ATF6).
  • To examine the interplay between ER and mitochondria in kidney disease.
  • To discuss the link between renal injury mediators, particularly vascular growth factors, and ER stress/UPR in AKI and CKD, identifying potential therapeutic targets.

Main Methods:

  • Literature review focusing on cellular mechanisms of ER stress and UPR in kidney disease.
  • Analysis of the interplay between ER and mitochondria.
  • Examination of the relationship between vascular growth factors and ER stress in renal pathophysiology.

Main Results:

  • ER stress, activated by cellular insults, triggers the UPR.
  • The UPR involves major branches: PERK, IRE1α, and ATF6.
  • ER-mitochondria crosstalk is crucial in the pathophysiology of kidney diseases.

Conclusions:

  • ER stress and UPR are central to AKI and CKD pathogenesis.
  • Targeting ER stress and UPR pathways, along with their interaction with mitochondria and growth factors, offers promising avenues for novel kidney disease therapies.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
388
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
619
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.0K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
238
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
515